Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 2
2002 1
2003 1
2004 1
2005 4
2006 9
2007 9
2008 7
2009 8
2010 10
2011 3
2012 10
2013 4
2014 3
2015 11
2016 8
2017 4
2018 4
2019 1
2020 1
2021 9
2022 12
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Related Articles by Review for PMID: 19903416

121 results

Results by year

Filters applied: . Clear all
Page 1
Chondroitin for osteoarthritis.
Singh JA, Noorbaloochi S, MacDonald R, Maxwell LJ. Singh JA, et al. Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD005614. doi: 10.1002/14651858.CD005614.pub2. Cochrane Database Syst Rev. 2015. PMID: 25629804 Free PMC article. Review.
Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
Sutcliffe P, Connock M, Pulikottil-Jacob R, Kandala NB, Suri G, Gurung T, Grove A, Shyangdan D, Briscoe S, Maheswaran H, Clarke A. Sutcliffe P, et al. Health Technol Assess. 2013 Nov;17(53):1-499, v-vi. doi: 10.3310/hta17530. Health Technol Assess. 2013. PMID: 24280231 Free PMC article. Review.
Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.
Clarke A, Pulikottil-Jacob R, Grove A, Freeman K, Mistry H, Tsertsvadze A, Connock M, Court R, Kandala NB, Costa M, Suri G, Metcalfe D, Crowther M, Morrow S, Johnson S, Sutcliffe P. Clarke A, et al. Health Technol Assess. 2015 Jan;19(10):1-668, vii-viii. doi: 10.3310/hta19100. Health Technol Assess. 2015. PMID: 25634033 Free PMC article. Review.
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C. Bond M, et al. Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210. Health Technol Assess. 2012. PMID: 22541366 Free PMC article. Review.
121 results